Solid Biosciences
SLDB
SLDB
35 hedge funds and large institutions have $85.3M invested in Solid Biosciences in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 17 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
41% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 17
76% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 29
Holders
35
Holding in Top 10
–
Calls
$216K
Puts
$5K
Top Buyers
| 1 | +$14M | |
| 2 | +$14M | |
| 3 | +$14M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$7.63M |
| 5 |
CCM
CAAS Capital Management
New York
|
+$4.81M |
Top Sellers
| 1 | -$4.2M | |
| 2 | -$373K | |
| 3 | -$243K | |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$153K |
| 5 |
E
Ergoteles
New York
|
-$95K |